The global neurovascular devices market size is estimated to reach USD 11.91 billion by 2033, registering a CAGR of 5.48% from 2025 to 2033, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.
One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.
The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.
For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).
Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.
Request a free sample copy or view report summary: Neurovascular Devices Market Report
By device, cerebral embolization and aneurysm coiling devices segment held the largest market share of around 37.56% in 2024. Coil embolization is a minimally invasive procedure for the treatment of aneurysms, wherein, the material closes the sac and reduces the risk of bleeding.
By therapeutic application, stroke segment held the largest market share of around 56.85% in 2024, owing to the factors such as increasing prevalence of hypertension, stroke, and other neurological disorders.
By size, the 0.021" segment held the largest market share of around 26.99% in 2024. Segment growth can be attributed to various advantages provided by the 0.021” devices, along with various product launches and product approvals.
By end-use, the hospitals held the largest market share of around 70.82% in 2024. The growth of this segment can be attributed primarily to the increasing patient pool suffering from neurovascular disorders, such as ischemic & hemorrhagic stroke, brain aneurysm, Traumatic brain injury (TBI), and Arteriovenous Malformation (AVM).
North America neurovascular devices dominated the market with a share of 27.40% in 2024, owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region.
Grand View Research has segmented the global neurovascular devices market based on the device, therapeutic application, size, end-use, and region:
Neurovascular Devices Device Outlook (Revenue, USD Million, 2021 - 2033)
Cerebral Embolization and Aneurysm Coiling Devices
Embolic coils
Flow diversion devices
Liquid embolic agents
Cerebral Angioplasty and Stenting Systems
Carotid artery stents
Embolic protection systems
Neurothrombectomy Devices
Clot retrieval devices
Suction devices/aspiration catheters
Vascular snares
Support Devices
Micro catheters
Micro guidewires
Trans Radial Access Devices
Neurovascular Devices Therapeutic Application Outlook (Revenue, USD Million, 2021 - 2033)
Stroke
Cerebral Artery
Cerebral Aneurysm
Aneurysmal Subarachnoid Hemorrhage
Others
Others
Neurovascular Devices Size (in Inches) Outlook (Revenue, USD Million, 2021 - 2033)
0.027"
0.021"
0.071"
0.017"
0.019"
0.013"
0.058"
0.068"
Others
Neurovascular Devices End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Specialty Clinics
Others
Neurovascular Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Neurovascular Devices Market
Medtronic
Stryker
Johnson & Johnson and its affiliates
Johnson & Johnson and its affiliates
MicroPort Scientific Corporation
Terumo Corporation
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
NeuroSafe Medical Co., Ltd.
Rapid Medical
Evasc Neurovascular Enterprises
Lepu Medical Technology(Beijing)Co., Ltd.
Acandis GmbH
phenox GmbH
"The quality of research they have done for us has been excellent..."